m<sup>6</sup>A epitranscriptomic regulation of tissue homeostasis during primate aging.

Wu, Zeming; Lu, Mingming; Liu, Di; Shi, Yue; Ren, Jie; Wang, Si; Jing, Ying; Zhang, Sheng et al. · Nat Aging · 2023

basic_science · Level V

Where this comes from

Abstract

How N<sup>6</sup>-methyladenosine (m<sup>6</sup>A), the most abundant mRNA modification, contributes to primate tissue homeostasis and physiological aging remains elusive. Here, we characterize the m<sup>6</sup>A epitranscriptome across the liver, heart and skeletal muscle in young and old nonhuman primates. Our data reveal a positive correlation between m<sup>6</sup>A modifications and gene expression homeostasis across tissues as well as tissue-type-specific aging-associated m<sup>6</sup>A dynamics. Among these tissues, skeletal muscle is the most susceptible to m<sup>6</sup>A loss in aging and shows a reduction in the m<sup>6</sup>A methyltransferase METTL3. We further show that METTL3 deficiency in human pluripotent stem cell-derived myotubes leads to senescence and apoptosis, and identify NPNT as a key element downstream of METTL3 involved in myotube homeostasis, whose expression and m<sup>6</sup>A levels are both decreased in senescent myotubes. Our study provides a resource for elucidating m<sup>6</sup>A-mediated mechanisms of tissue aging and reveals a METTL3-m<sup>6</sup>A-NPNT axis counteracting aging-associated skeletal muscle degeneration.

Medical subject headings